Literature DB >> 24615903

In vivo (31)P magnetic resonance spectroscopy of the human liver at 7 T: an initial experience.

Marek Chmelik1, Michal Považan, Martin Krššák, Stephan Gruber, Martin Tkačov, Siegfried Trattnig, Wolfgang Bogner.   

Abstract

Phosphorus ((31) P) MRS is a powerful tool for the non-invasive investigation of human liver metabolism. Four in vivo (31) P localization approaches (single voxel image selected in vivo spectroscopy (3D-ISIS), slab selective 1D-ISIS, 2D chemical shift imaging (CSI), and 3D-CSI) with different voxel volumes and acquisition times were demonstrated in nine healthy volunteers. Localization techniques provided comparable signal-to-noise ratios normalized for voxel volume and acquisition time differences, Cramer-Rao lower bounds (8.7 ± 3.3%1D-ISIS , 7.6 ± 2.5%3D-ISIS , 8.6 ± 4.2%2D-CSI , 10.3 ± 2.7%3D-CSI ), and linewidths (50 ± 24 Hz1D-ISIS , 34 ± 10 Hz3D-ISIS , 33 ± 10 Hz2D-CSI , 34 ± 11 Hz3D-CSI ). Longitudinal (T1 ) relaxation times of human liver metabolites at 7 T were assessed by 1D-ISIS inversion recovery in the same volunteers (n = 9). T1 relaxation times of hepatic (31) P metabolites at 7 T were the following: phosphorylethanolamine - 4.41 ± 1.55 s; phosphorylcholine - 3.74 ± 1.31 s; inorganic phosphate - 0.70 ± 0.33 s; glycerol 3-phosphorylethanolamine - 6.19 ± 0.91 s; glycerol 3-phosphorylcholine - 5.94 ± 0.73 s; γ-adenosine triphosphate (ATP) - 0.50 ± 0.08 s; α-ATP - 0.46 ± 0.07 s; β-ATP - 0.56 ± 0.07 s. The improved spectral resolution at 7 T enabled separation of resonances in the phosphomonoester and phosphodiester spectral region as well as nicotinamide adenine dinucleotide and uridine diphosphoglucose signals. An additional resonance at 2.06 ppm previously assigned to phosphoenolpyruvate or phosphatidylcholine is also detectable. These are the first (31) P metabolite relaxation time measurements at 7 T in human liver, and they will help in the exploration of new, exciting questions in metabolic research with 7 T MR.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  7 T; T1; human liver; localization; phosphorus; relaxation; spectroscopic imaging; spectroscopy

Mesh:

Substances:

Year:  2014        PMID: 24615903     DOI: 10.1002/nbm.3084

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  17 in total

Review 1.  Assessing tissue metabolism by phosphorous-31 magnetic resonance spectroscopy and imaging: a methodology review.

Authors:  Yuchi Liu; Yuning Gu; Xin Yu
Journal:  Quant Imaging Med Surg       Date:  2017-12

2.  Phosphatidylcholine contributes to in vivo (31)P MRS signal from the human liver.

Authors:  Marek Chmelík; Ladislav Valkovič; Peter Wolf; Wolfgang Bogner; Martin Gajdošík; Emina Halilbasic; Stephan Gruber; Michael Trauner; Michael Krebs; Siegfried Trattnig; Martin Krššák
Journal:  Eur Radiol       Date:  2015-01-11       Impact factor: 5.315

3.  Measuring short-term liver metabolism non-invasively: postprandial and post-exercise ¹H and ³¹P MR spectroscopy.

Authors:  Antti Hakkarainen; Jesper Lundbom; Esa K Tuominen; Marja-Riitta Taskinen; Kirsi H Pietiläinen; Nina Lundbom
Journal:  MAGMA       Date:  2014-06-04       Impact factor: 2.310

4.  (31)P CSI of the human brain in healthy subjects and tumor patients at 9.4 T with a three-layered multi-nuclear coil: initial results.

Authors:  Christian Mirkes; Gunamony Shajan; Grzegorz Chadzynski; Kai Buckenmaier; Benjamin Bender; Klaus Scheffler
Journal:  MAGMA       Date:  2016-01-25       Impact factor: 2.310

5.  Application of localized ³¹P MRS saturation transfer at 7 T for measurement of ATP metabolism in the liver: reproducibility and initial clinical application in patients with non-alcoholic fatty liver disease.

Authors:  Ladislav Valkovič; Martin Gajdošík; Stefan Traussnigg; Peter Wolf; Marek Chmelík; Christian Kienbacher; Wolfgang Bogner; Michael Krebs; Michael Trauner; Siegfried Trattnig; Martin Krššák
Journal:  Eur Radiol       Date:  2014-03-20       Impact factor: 5.315

6.  Feasibility of 31 P spectroscopic imaging at 7 T in lung carcinoma patients.

Authors:  Quincy Q van Houtum; Firdaus F A A Mohamed Hoesein; Joost J J C Verhoeff; Peter P S N van Rossum; Anne A S R van Lindert; Tijl T A van der Velden; Wybe W J M van der Kemp; Dennis D W J Klomp; Catalina C S Arteaga de Castro
Journal:  NMR Biomed       Date:  2019-11-17       Impact factor: 4.044

7.  PCA denoising and Wiener deconvolution of 31 P 3D CSI data to enhance effective SNR and improve point spread function.

Authors:  Martijn Froeling; Jeanine J Prompers; Dennis W J Klomp; Tijl A van der Velden
Journal:  Magn Reson Med       Date:  2021-02-01       Impact factor: 4.668

8.  Improving the hyperpolarization of (31)P nuclei by synthetic design.

Authors:  Michael J Burns; Peter J Rayner; Gary G R Green; Louise A R Highton; Ryan E Mewis; Simon B Duckett
Journal:  J Phys Chem B       Date:  2015-04-06       Impact factor: 2.991

9.  Open-label phase II study evaluating safety and efficacy of the non-steroidal farnesoid X receptor agonist PX-104 in non-alcoholic fatty liver disease.

Authors:  Stefan Traussnigg; Emina Halilbasic; Harald Hofer; Petra Munda; Tatjana Stojakovic; Günter Fauler; Karl Kashofer; Martin Krssak; Michael Wolzt; Michael Trauner
Journal:  Wien Klin Wochenschr       Date:  2020-09-15       Impact factor: 1.704

Review 10.  Accelerated MR spectroscopic imaging-a review of current and emerging techniques.

Authors:  Wolfgang Bogner; Ricardo Otazo; Anke Henning
Journal:  NMR Biomed       Date:  2020-05-12       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.